newsfilter
← Latest News
GlobeNewswire·

VectivBio Announces Closing of $125 Million Underwritten Offering of Ordinary Shares

BASEL, Switzerland, Oct. 18, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG ("VectivBio") (NASDAQ:VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare